Published on Sat, Dec 09, 2006 at 12:10 | Source : Moneycontrol.com
Updated at Sat, Dec 09, 2006 at 12:29
Like this story, share it with millions of investors on M3
0
Like this story, share it with millions of investors on M3
Pharma, biotech firms keen on European market
It's `Europe calling', for Indian pharma and biotech companies, especially from Hyderabad. In just about a year, half a dozen companies have either acquired companies, have forged license agreements or been acquired.
It's `Europe calling', for Indian pharma and biotech companies, especially from Hyderabad. In just about a year, half a dozen companies have either acquired companies, forged license agreements or been acquired.
The big ticket acquisition of Betapharm - Germany's fourth largest generic pharma company, by Dr Reddy's Laboratories in February for Rs 2,250 crore, seems to have set the ball rolling.
Biotechnology firms - Ocimum Biosolutions, Shantha Biotechnics and Bharat Biotech International Ltd - have also been in the spotlight.
The goal seems to be two-way for Indian companies - a foothold and expansion into the European markets, and for the European companies, a means of gaining access to the growing Indian and Asian markets.
|
Budget: 2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget | Budget 2012
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide | History India
| Up Polls | Latest News
| Uninor | Aurobindo Pharma | Bihar | Vodafone Essar | Mahindra Satyam | Reliance Industries | BSE Sensex | Montek Singh Ahluwalia | Reliance Communications | Commodities 
